Is the FDA embracing quackery? A draft proposal recommends that doctors learn about acupuncture and chiropractic for pain management.
Chiropractors and acupuncturists have lobbied for a greater role in treating pain. They might well have won it. Last week, the FDA released proposed changes Wednesday to its blueprint on educating health care providers about treating pain, which now recommend that doctors learn about chiropractic care and acupuncture as therapies that might help patients avoid opioids. There's still time to stop this.
FDA issues warning letter to “holistic” practitioner offering thermography for breast cancer detection
Thermography for breast cancer detection is one of more than 65 products the FDA just announced it is going after for fraudulently claiming to prevent, diagnose, treat or cure cancer.
Ill-advised right-to-try bills are spreading like kudzu through state legislatures. Now federal legislators want to insert right-to-try language into the bill that funds FDA drug approval. Given the support of powerful Republicans like Vice President Mike Pence for right-to-try, is it too late to stop this juggernaut and protect patients?
A week after Donald Trump was elected, I speculated about how he would affect medical science policy. Now, 80 days into the Trump administration, we have some observations.
I almost purchased a worthless homeopathic eye remedy at CVS for a cancer patient. I'm taking action to try to stop this from happening to others.
Is the ACCME cracking down on quackery in continuing medical education (CME) offerings? Richard Jaffe thinks so.
Richard Jaffe, a lawyer who has made a career out of defending quacks like Dr. Stanislaw Burzynski, thinks that the ACCME, the main accrediting body for continuing medical education (CME) credits, is cracking down on "complementary and alternative medicine" CME courses. That would be a very good thing indeed, but is it really happening? More importantly, would it be enough?
The Texas Medical Board lets Stanislaw Burzynski off lightly: A cautionary tale of the failure of regulating medicine
After three years and countless twists and turns, the final decision by the Texas Medical Board on the sanctions to be imposed on Houston cancer quack Dr. Stanislaw Burzynski were announced on Friday. Sadly, they were not enough. The Burzynski saga should serve as a cautionary tale that the regulation of physicians and medicine is too lax, not too strict.
Donald Trump versus the FDA: Is the standard of evidence for drug approval actually too low rather than too high?
All of the candidates being considered by President Trump for FDA Commissioner believe that the FDA is too strict in its standards for approving new drugs. In a commentary in Nature last week, two bioethicists argued that, at least in terms of preclinical data, the standard of evidence is actually too low. Which is correct?
Not every article and study that pops up my feeds in the world of pseudo-medicine is worthy of a complete blog post. But they need to be noticed and commented upon: FDA confirms elevated levels of belladonna in certain homeopathic teething products. Homeopaths prove water not toxic to fish. Lots of acupuncture recommendations, little good data. Everything is CAM. And more! Duty...
Donald Trump's three most likely picks for FDA Commissioner all favor loosening drug approval standards. Two are cronies of Peter Thiel, of which one believes that the FDA shouldn't require evidence of efficacy, only safety, and the other believes that a "Yelp for drugs" would do a better job than the FDA. The third candidate is a bona fide, honest-to-goodness pharma shill....